Though the market looks promising, the major barrier in obtaining medical device approval in Japan market is the stringent Pharmaceuticals and Medical Devices Agency (PMDA) regulations that companies must abide by. To manage their product registrations and liaise with Japan’s regulatory authorities, all foreign medical device and pharmaceutical companies selling in Japan must assign a Japan DMAH agent.
Regulatory Authority: Pharmaceuticals and Medical Devices Agency (PMDA) working under the Ministry of Health Labour and Welfare (MHLW)
Regulation: Pharmaceuticals and Medical Devices Act (PMD Act)
Regulatory Pathway: Pre-Market Submission or Pre-Market Certification or Pre-Market Approval
Authorized Representative: MAH/D-MAH
QMS Requirement: Ordinance No. 169, MDSAP Certification